Alan Barge Would Serve on Zymeworks Inc.'s Board
Dr. Barge has unmatched expertise in oncology and biopharmaceutical drug development and commercialization. He joined AB after founding Carrick Therapeutics in the UK, which focused on early-stage oncology assets, and co-founding ASLAN Pharmaceuticals, a Singapore-based biopharmaceutical company that focuses on Asia-related cancers. Earlier in his career, Dr. Barge served as Vice President of Clinical and Head of Oncology and Infection at AstraZeneca, where he was responsible for building and managing a large development group and executing AstraZeneca's oncology portfolio globally. He also served as European Medical Director at Amgen.